COBO MARC (Principal Accounting Officer) received a stock award from BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2026ACC: 0001193125-26-390624
Officer· Principal Accounting Officer
Since Apr 2026
+52.53K
Net shares
Net buyer
$1.1K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
52.74K acquired · 203.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.04K
Price / share
—
Trade value
—
% of position
170.3%
9/10/2026
5.31K→14.34K
Common Stock
Direct
Shares
−203.00
Price / share
$5.52
Trade value
$1.12K
% of position
1.4%
9/10/2026
14.34K→14.14K
Total
Net shares
+8.84K
Net value
-$1.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | A · Award | +9.04K | — | — | 170.3% | 5.31K | 14.34K |
| Common Stock Direct | 9/10/2026 | F · Tax Withholding | −203.00 | $5.52 | $1.12K | 1.4% | 14.34K | 14.14K |
| Total | +8.84K | -$1.12K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
43.70K shares
Shares
+43.70K
Strike price
5.52
Held after
43.70K
Exercisable
—
9/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock43.70K shares | 9/10/2026 | A · Award | +43.70K | 5.52 | — | 43.70K |